Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
61 Patents
#3 in Danvers, MA
#335 in Massachusetts
#5,914 in US
#11,923 in the World
Cell Signaling Technology, Inc.
Forward Citations = 247
52 inventors:
Danvers, MA, United States of America
Cell Signaling Technology, Inc.
% Expired Patents = 9.8
CIPO Patents = 3
EPO Patents = 20
Trademarks = 25
Forward Citations = 247
Loading Chart...
Loading Chart...
52 inventors (with patents filed for the assignee):
Ailan Guo (29 out of 31 patents)
Ting-Lei Gu (21 out of 21 patents)
Herbert Haack (18 out of 18 patents)
4. Anthony Paul Possemato (17 out of 17 patents)
5. Klarisa Rikova (16 out of 28 patents)
6. Michael Comb (13 out of 14 patents)
7. Laura Sullivan (13 out of 13 patents)
8. Jian Yu (13 out of 19 patents)
9. Roberto Polakiewicz (13 out of 15 patents)
10. Joan MacNeill (12 out of 12 patents)
11. Albrecht Moritz (11 out of 12 patents)
12. John Edward Rush, Ii (10 out of 11 patents)
13. Katherine Eleanor Crosby (8 out of 8 patents)
14. Yi Tan (8 out of 9 patents)
15. Kimberly A Lee (7 out of 9 patents)
Core Competencies:
Mutant ALK Kinase
Cancer Diagnostics
ROS Expression
Polypeptide Detection
Mass Spectrometry
Monoclonal Antibodies
Signaling Pathways
Phosphorylation Sites
Immunoaffinity Isolation
EGFR Detection
Lung Cancer
Non-Small Cell Carcinoma
61 patents:
2. 11761005 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2023-09-19),
3. 11505833 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2022-11-22),
9. 10889818 - Translocation and mutant ROS kinase in human non-small cell lung carcinoma (2021-01-12),
10. 10870892 - Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer (2020-12-22),
11. 10670606 - Mass spectrometry analysis of mutant polypeptides in biological samples (2020-06-02),
Company Overview
Cell Signaling Technology, Inc., based in Danvers, MA, specializes in the development and manufacture of innovative tools for cancer diagnostics. The company focuses on advanced technologies such as mutant ALK kinase detection, ROS expression analysis, and polypeptide detection. Their expertise extends to mass spectrometry and monoclonal antibodies, facilitating in-depth research into signaling pathways and phosphorylation sites. By providing high-quality reagents and assays, Cell Signaling Technology supports the scientific community in understanding cancer biology and advancing therapeutic strategies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cell Signaling Technology, Inc.. Retrieved from https://idiyas.com/company/cell-signaling-technology
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
20 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]